Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.07 USD | +5.14% | +0.25% | -39.29% |
Sales 2024 * | 5.27M 6.72M | Sales 2025 * | 75.44M 96.12M | Capitalization | 769M 980M |
---|---|---|---|---|---|
Net income 2024 * | -103M -131M | Net income 2025 * | -65M -82.82M | EV / Sales 2024 * | 111 x |
Net cash position 2024 * | 184M 234M | Net cash position 2025 * | 146M 187M | EV / Sales 2025 * | 8.26 x |
P/E ratio 2024 * |
-12.8
x | P/E ratio 2025 * |
-30.4
x | Employees | 79 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.42% |
Latest transcript on Verona Pharma plc
1 day | +5.14% | ||
1 week | +0.25% | ||
1 month | -21.88% | ||
3 months | -29.91% | ||
6 months | -10.72% | ||
Current year | -39.29% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 20-01-31 | |
Mark Hahn
DFI | Director of Finance/CFO | 61 | 20-02-29 |
Kavita Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mahendra Shah
BRD | Director/Board Member | 79 | 16-06-16 |
Vikas Sinha
BRD | Director/Board Member | 60 | 16-09-11 |
David Ebsworth
CHM | Chairman | 69 | 14-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 12.07 | +5.14% | 1,338,260 |
24-05-30 | 11.48 | -3.12% | 561,383 |
24-05-29 | 11.85 | -4.67% | 762,324 |
24-05-28 | 12.43 | +3.24% | 1,260,700 |
24-05-24 | 12.04 | +0.33% | 419,884 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.29% | 979M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- VRNA Stock